Wockhardt LimitedNSE: WOCKPHARMA

Press Release Dec 01 2025

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release US FDA Accepts Wockhardt s New Drug Application for Breakthrough Antibiotic Zaynich .

View Attachment